Cargando…

Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems

Postmortem studies in patients with schizophrenia (SCZ) have revealed deficits in myelination, abnormalities in myelin gene expression and altered numbers of oligodendrocytes in the brain. However, gaining mechanistic insight into oligodendrocyte (OL) dysfunction and its contribution to SCZ has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raabe, Florian J., Galinski, Sabrina, Papiol, Sergi, Falkai, Peter G., Schmitt, Andrea, Rossner, Moritz J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242875/ https://www.ncbi.nlm.nih.gov/pubmed/30451850 http://dx.doi.org/10.1038/s41537-018-0066-4

Ejemplares similares

Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction
por: Raabe, Florian J., et al.
Publicado: (2019)

Polygenic burden associated to oligodendrocyte precursor cells and radial glia influences the hippocampal volume changes induced by aerobic exercise in schizophrenia patients
por: Papiol, Sergi, et al.
Publicado: (2019)

Expression of Lineage Transcription Factors Identifies Differences in Transition States of Induced Human Oligodendrocyte Differentiation
por: Raabe, Florian J., et al.
Publicado: (2022)

Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors
por: Schmitt, Andrea, et al.
Publicado: (2022)

Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis
por: Falkai, Peter, et al.
Publicado: (2023)

Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat
por: Stephan, Marius, et al.
Publicado: (2022)

Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study
por: Schmitt, Andrea, et al.
Publicado: (2022)

Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules
por: Cassoli, Juliana Silva, et al.
Publicado: (2015)

Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits
por: Falkai, Peter, et al.
Publicado: (2016)

11.3 CLINICAL AND NEUROBIOLOGICAL EFFECTS OF A CONTINUOUS AEROBIC ENDURANCE TRAINING IN MULTI-EPISODE SCHIZOPHRENIA PATIENTS
por: Malchow, Berend, et al.
Publicado: (2018)

Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives
por: Popovic, David, et al.
Publicado: (2019)

Cellular pathology in the limbic system in schizophrenia
por: Schmitt, Andrea, et al.
Publicado: (2023)

Improvement in daily functioning after aerobic exercise training in schizophrenia is sustained after exercise cessation
por: Falkai, Peter, et al.
Publicado: (2021)

Polygenic risk has an impact on the structural plasticity of hippocampal subfields during aerobic exercise combined with cognitive remediation in multi-episode schizophrenia
por: Papiol, S, et al.
Publicado: (2017)

Pathway sensor-based functional genomics screening identifies modulators of neuronal activity
por: Herholt, Alexander, et al.
Publicado: (2018)

Spironolactone is an antagonist of NRG1‐ERBB4 signaling and schizophrenia‐relevant endophenotypes in mice
por: Wehr, Michael C, et al.
Publicado: (2017)

Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality
por: Schmitt, Andrea, et al.
Publicado: (2018)

Modulation of cognition and neuronal plasticity in gain- and loss-of-function mouse models of the schizophrenia risk gene Tcf4
por: Badowska, D. M., et al.
Publicado: (2020)

Oligodendrocytes in Schizophrenia
por: Xu, Haiyun, et al.
Publicado: (2011)

Extracellular vesicle approach to major psychiatric disorders
por: Oraki Kohshour, Mojtaba, et al.
Publicado: (2022)

Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
por: Gouvêa-Junqueira, Danielle, et al.
Publicado: (2020)

Multiplexed profiling of GPCR activities by combining split TEV assays and EXT-based barcoded readouts
por: Galinski, Sabrina, et al.
Publicado: (2018)

Failed regeneration and inflammation in schizophrenia: two sides of the same coin?
por: Falkai, Peter, et al.
Publicado: (2022)

Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles
por: Oraki Kohshour, Mojtaba, et al.
Publicado: (2022)

Schizophrenia as a disorder of disconnectivity
por: Schmitt, Andrea, et al.
Publicado: (2011)

Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients
por: Schmitt, Andrea, et al.
Publicado: (2012)

Treatment of negative symptoms in schizophrenia: a challenge for clinical research
por: Schmitt, Andrea, et al.
Publicado: (2023)

Affected neural networks as basis of disturbed motor function in schizophrenia
por: Schmitt, Andrea, et al.
Publicado: (2020)

T102. AN INVESTIGATION OF SCHIZOPHRENIA-BIPOLAR SUBGROUPS WITH GENETIC AND PROGNOSTIC VALIDATION
por: Dwyer, Dominic, et al.
Publicado: (2018)

The role of the cerebellum in schizophrenia: from cognition to molecular pathways
por: Yeganeh-Doost, Peyman, et al.
Publicado: (2011)

The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription
por: Katsel, Pavel, et al.
Publicado: (2019)

The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia
por: Misiak, Błażej, et al.
Publicado: (2023)

Human-specific evolutionary markers linked to foetal neurodevelopment modulate brain surface area in schizophrenia
por: Guardiola-Ripoll, Maria, et al.
Publicado: (2023)

Nonpharmacological treatment of dyscognition in schizophrenia: effects  of aerobic exercise 
por: Maurus, Isabel, et al.
Publicado: (2019)

Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis
por: Gong, Zhenxiang, et al.
Publicado: (2022)

Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases
por: Han, Seungwan, et al.
Publicado: (2022)

MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia
por: Guest, Paul C., et al.
Publicado: (2015)

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence
por: Malchow, Berend, et al.
Publicado: (2012)

Modulation of Oligodendrocyte Differentiation by Mechanotransduction
por: Lourenço, Tânia, et al.
Publicado: (2016)

Biomarkers and neurobiology of schizophrenia
por: Falkai, Peter, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7mrc2ch6go82vumfh7a136ohfl